REFERENCES
1. Bogani G, Murgia F, Ditto A, Raspagliesi F. Sentinel node mapping vs.
lymphadenectomy in endometrial cancer: A systematic review and
meta-analysis. Gynecol Oncol. 2019;153(3):676–83.
2. Pölcher M, Rottmann M, Brugger S, Mahner S, Dannecker C, Kiechle M,
et al. Lymph node dissection in endometrial cancer and clinical outcome:
A population-based study in 5546 patients. Gynecol Oncol.
2019;154(1):65–71.
3. Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A,
Ledermann J, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial
Cancer: Diagnosis, Treatment and Follow-up. Int J Gynecol Cancer.
2016;26(1):2–30.
4. Prodromidou A, Machairas N, Spartalis E, Kostakis ID, Iavazzo C,
Moris D, et al. Transperitoneal Versus Extraperitoneal Laparoscopic
Lymphadenectomy for Gynecological Malignancies: A Systematic Review and
Meta-analysis. Anticancer Res. 2018;38(8):4677–81.
5. Ind T, Laios A, Hacking M, Nobbenhuis M. A comparison of operative
outcomes between standard and robotic laparoscopic surgery for
endometrial cancer: A systematic review and meta-analysis. Int J Med
Robot. 2017;13(4):e1851.
6. Kuroda K, Yamamoto Y, Yanagisawa M, Kawata A, Akiba N, Suzuki K, et
al. Risk factors and a prediction model for lower limb lymphedema
following lymphadenectomy in gynecologic cancer: A hospital-based
retrospective cohort study. BMC Womens Health. 2017;17(1):50.
7. Kondalsamy-Chennakesavan S, Janda M, Gebski V, Baker J, Brand A, Hogg
R, et al. Risk factors to predict the incidence of surgical adverse
events following open or laparoscopic surgery for apparent early stage
endometrial cancer: Results from a randomised controlled trial. Eur J
Cancer. 2012;48(14):2155–62.
8. Shim SH, Lee SJ, Dong M, Suh JH, Kim SY, Lee JH, et al. Prediction
model for 30-day morbidity after gynecological malignancy surgery. PLoS
One. 2017;12(6):e0178610.
9. Bakkum-Gamez JN, Dowdy SC, Borah BJ, Haas LR, Mariani A, Martin JR,
et al. Predictors and costs of surgical site infections in patients with
endometrial cancer. Gynecol Oncol. 2013;130(1):100–6.
10. Gerestein CG, Nieuwenhuyzen-de Boer GM, Eijkemans MJ, Kooi GS,
Burger CW. Prediction of 30-day morbidity after primary cytoreductive
surgery for advanced stage ovarian cancer. Eur J Cancer.
2010;46(1):102–9.
11. Giugale LE, Di Santo N, Smolkin ME, Havrilesky LJ, Modesitt SC.
Beyond mere obesity: Effect of increasing obesity classifications on
hysterectomy outcomes for uterine cancer/hyperplasia. Gynecol Oncol.
2012;127(2):326–31.
12. Orekoya O, Samson ME, Trivedi T, Vyas S, Steck SE. The Impact of
Obesity on Surgical Outcome in Endometrial Cancer Patients: A Systematic
Review. J Gynecol Surg. 2016;32(3):149–57.
13. Uccella S, Bonzini M, Palomba S, Fanfani F, Ceccaroni M, Seracchioli
R, et al. Impact of Obesity on Surgical Treatment for Endometrial
Cancer: A Multicenter Study Comparing Laparoscopy vs Open Surgery, with
Propensity-Matched Analysis. J Minim Invasive Gynecol.
2016;23(1):53–61.
14. Aune D, Navarro Rosenblatt DA, Chan DSM, Vingeliene S, Abar L,
Vieira AR, et al. Anthropometric factors and endometrial cancer risk: A
systematic review and dose-response meta-analysis of prospective
studies. Ann Oncol. 2015;26(8):1635–48.
15. Seki Y, Ohue M, Sekimoto M, Takiguchi S, Takemasa I, Ikeda M, et al.
Evaluation of the technical difficulty performing laparoscopic resection
of a rectosigmoid carcinoma: visceral fat reflects technical difficulty
more accurately than body mass index. Surg Endosc. 2007;21(6):929–34.
16. Kang J, Baek S-E, Kim T, Hur H, Min BS, Lim JS, et al. Impact of fat
obesity on laparoscopic total mesorectal excision: more reliable
indicator than body mass index. Int J Colorectal Dis.
2012;27(4):497–505.
17. Watanabe J, Tatsumi K, Ota M, Suwa Y, Suzuki S, Watanabe A, et al.
The impact of visceral obesity on surgical outcomes of laparoscopic
surgery for colon cancer. Int J Colorectal Dis. 2014;29(3):343–51.
18. Ballian N, Lubner MG, Munoz A, Harms BA, Heise CP, Foley EF, et al.
Visceral obesity is associated with outcomes of total mesorectal
excision for rectal adenocarcinoma. J Surg Oncol. 2012;105(4):365–70.
19. Palomba S, Zupi E, Russo T, Oppedisano R, Manguso F, Falbo A, et al.
Presurgical assessment of intraabdominal visceral fat in obese patients
with early-stage endometrial cancer treated with laparoscopic approach:
Relationships with early laparotomic conversions. J Minim Invasive
Gynecol. 2007;14(2):195–201.
20. Zamboni M, Turcato E, Armellini F, Kahn H, Zivelonghi A, Santana H,
et al. Sagittal abdominal diameter as a practical predictor of visceral
fat. Int J Obes. 1998;22(7):655–60.
21. Molokhia AA. Waist circumference is better than body mass index, but
sagittal anterior diameter may be even better. Br J Anaesth.
2017;118(2):274.
22. Biswas N, Hogston P. Surgical risk from obesity in gynaecology.
Obstet Gynaecol. 2011;13(2):87–91.
23. Díaz-Feijoo B, Bebia V, Hernández A, Gilabert-Estalles J,
Franco-Camps S, de la Torre J, et al. Surgical complications comparing
extraperitoneal vs transperitoneal laparoscopic aortic staging in early
stage ovarian and endometrial cancer. Gynecol Oncol. 2021;160(1):83-90.
24. Díaz-Feijoo B, Correa-Paris A, Pérez-Benavente A, Franco-Camps S,
Sánchez-Iglesias JL, Cabrera S, et al. Prospective Randomized Trial
Comparing Transperitoneal Versus Extraperitoneal Laparoscopic Aortic
Lymphadenectomy for Surgical Staging of Endometrial and Ovarian Cancer:
The STELLA Trial. Ann Surg Oncol. 2016;23(9):2966–74.
25. Yim JY, Kim D, Lim SH, Park MJ, Choi SH, Lee CH, et al. Sagittal
Abdominal Diameter Is a Strong Anthropometric Measure of Visceral
Adipose Tissue in the Asian General Population. Diabetes Care.
2010;33(12):2665–70.
26. Dell-Kuster S, Gomes N V., Gawria L, Aghlmandi S, Aduse-Poku M,
Bissett I, et al. Prospective validation of classification of
intraoperative adverse events (ClassIntra): international, multicentre
cohort study. BMJ. 2020;370:1–11.
27. Dindo D, Demartines N, Clavien P-A. Classification of Surgical
Complications. Ann Surg. 2004;240(2):205–13.
28. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a
combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.
29. Bland JM, Altman DG. Measuring agreement in method comparison
studies. Stat Methods Med Res. 1999;8(2):135–60.
30. Chinchilli VM, Martel JK, Kumanyika S, Lloyd T. A Weighted
Concordance Correlation Coefficient for Repeated Measurement Designs.
Biometrics. 1996;52(1):341.
31. Salman MC, Usubutun A, Ozlu T, Boynukalin K, Yuce K. Obesity does
not affect the number of retrieved lymph nodes and the rate of
intraoperative complications in gynecologic cancers. J Gynecol Oncol.
2010;21(1):24.
32. Helm CW, Arumugam C, Gordinier ME, Metzinger DS, Pan J, Rai SN.
Laparoscopic surgery for endometrial cancer: increasing body mass index
does not impact postoperative complications. J Gynecol Oncol.
2011;22(3):168.
33. Harrison RF, Mcnamara JE, Beaumont CB, Sadowski EA, Chappell RJ,
Shahzad MM, et al. Using simple radiologic measurements to anticipate
surgical challenge in endometrial cancer: a prospective study. Int J
Gynecol Cancer. 2019;29(1):102–7.
34. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR,
et al. Prospective assessment of survival, morbidity, and cost
associated with lymphadenectomy in low-risk endometrial cancer. Gynecol
Oncol. 2012;127(1):5–10.
35. Doll KM, Barber EL, Bensen JT, Revilla MC, Snavely AC, Bennett A V.,
et al. The impact of surgical complications on health-related quality of
life in women undergoing gynecologic and gynecologic oncology
procedures: a prospective longitudinal cohort study. Am J Obstet
Gynecol. 2016;215(4):457.e1-457.e13.
36. Clark RM, Lee MS, Alejandro Rauh‐Hain J, Hall T, Boruta DM, del
Carmen MG, et al. Surgical Apgar Score and prediction of morbidity in
women undergoing hysterectomy for malignancy. Gynecol Oncol.
2015;136(3):516–20.
37. Bhandoria G, Mane JD. Can Surgical Apgar Score (SAS) Predict
Postoperative Complications in Patients Undergoing Gynecologic
Oncological Surgery? Indian J Surg Oncol. 2020;11(1):60–5.
38. Teoh D, Halloway RN, Heim J, Vogel RI, Rivard C. Evaluation of the
American College of Surgeons National Surgical Quality Improvement
Program Surgical Risk Calculator in Gynecologic Oncology Patients
Undergoing Minimally Invasive Surgery. J Minim Invasive Gynecol.
2017;24(1):48–54.
39. Iyer R, Gentry-Maharaj A, Nordin A, Burnell M, Liston R, Manchanda
R, et al. Predictors of complications in gynaecological oncological
surgery: a prospective multicentre study (UKGOSOC—UK gynaecological
oncology surgical outcomes and complications). Br J Cancer.
2015;112(3):475–84.
40. Zullo F, Falbo A, Palomba S. Safety of laparoscopy vs laparotomy in
the surgical staging of endometrial cancer: a systematic review and
metaanalysis of randomized controlled trials. Am J Obstet Gynecol.
2012;207(2):94–100.
41. Barrie A, Freeman AH, Lyon L, Garcia C, Conell C, Abbott LH, et al.
Classification of Postoperative Complications in Robotic-assisted
Compared With Laparoscopic Hysterectomy for Endometrial Cancer. J Minim
Invasive Gynecol. 2016;23(7):1181–8.
42. Jørgensen SL, Mogensen O, Wu C, Lund K, Iachina M, Korsholm M, et
al. Nationwide Introduction of Minimally Invasive Robotic Surgery for
Early-Stage Endometrial Cancer and Its Association With Severe
Complications. JAMA Surg. 2019;154(6):530.
43. The COMET Initiative. COMET database [Internet]. [cited 2020
Nov 20]. Available from: https://www.comet-initiative.org/studies/